Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17579184 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic;   Lymphomas;   Multiple Myeloma;   Myelodysplastic Syndrome;   Leukemia, Lymphocytic, Acute;   Leukemia, Lymphocytic, Chronic;   AML
Interventions: Procedure: Donor Lymphocyte Infusion;   Drug: Induction Chemotherapy + DLI

Study has passed its completion date and status has not been verified in more than two years.